Go Ikeda

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Drug Administration

Locally Advanced

Liver Metastases

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Go Ikeda, Jun Miyakoshi, Shun Yamamoto, Ken Kato
Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma. Future oncology (London, England) 20 (11) (2023)
Go Ikeda, Jun Miyakoshi, Shun Yamamoto, Ken Kato
Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma. Future oncology (London, England) (2023)
Go Ikeda, Jun Miyakoshi, Shun Yamamoto, Ken Kato
Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma. Future oncology (London, England) 20 (11) (2023)